Detalhe da pesquisa
1.
In vitro miltefosine and amphotericin B susceptibility of strains and clinical isolates of Leishmania species endemic in Brazil that cause tegumentary leishmaniasis.
Exp Parasitol
; 246: 108462, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642298
2.
Isolation, typing, and drug susceptibility of Leishmania (Leishmania) infantum isolates from dogs of the municipality of Embu das Artes, an endemic region for canine leishmaniasis in Brazil.
Parasitol Res
; 121(9): 2683-2695, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802163
3.
In Vitro Drug Susceptibility of a Leishmania (Leishmania) infantum Isolate from a Visceral Leishmaniasis Pediatric Patient after Multiple Relapses.
Trop Med Infect Dis
; 8(7)2023 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505650
4.
Models for cytotoxicity screening of antileishmanial drugs: what has been done so far?
Int J Antimicrob Agents
; 60(2): 106612, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691601
5.
Susceptibility to paromomycin in clinical isolates and reference strains of Leishmania species responsible for tegumentary leishmaniasis in Brazil.
Acta Trop
; 215: 105806, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33385363
6.
Activity of paromomycin against Leishmania amazonensis: Direct correlation between susceptibility in vitro and the treatment outcome in vivo.
Int J Parasitol Drugs Drug Resist
; 14: 91-98, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33011651